The principles of RT-QuIC developed in prion disease diagnosis have subsequently been applied to biosamples in a range of neurodegenerative diseases with proposed proteopathic seeds including those composed of β-amyloid, α-synuclein, tau, and TDP-43, summarised in Table 1. The gene discussed is MAPT; the disease is neurodegenerative disease.